• Fecal Immunochemical Test (FIT) and Helicobacter pylori Stool Antigen Co-Testing for Gastric Cancer

  • 2024/09/30
  • 再生時間: 12 分
  • ポッドキャスト

Fecal Immunochemical Test (FIT) and Helicobacter pylori Stool Antigen Co-Testing for Gastric Cancer

  • サマリー

  • Gastric cancer is a leading cause of cancer death globally. Chronic H pylori infection is the primary cause of gastric cancer, responsible for at least 80% of the new cases. Constanza Camargo, PhD, of the National Cancer Institute joins JAMA Associate Editor John M. Inadomi, MD, to discuss co-testing with FIT and H pylori stool antigen to help prevent gastric cancer.

    Related Content:

    • Fecal Immunochemical Test and Helicobacter pylori Stool Antigen Co-Testing
    • Screening for Helicobacter pylori to Prevent Gastric Cancer
    続きを読む 一部表示

あらすじ・解説

Gastric cancer is a leading cause of cancer death globally. Chronic H pylori infection is the primary cause of gastric cancer, responsible for at least 80% of the new cases. Constanza Camargo, PhD, of the National Cancer Institute joins JAMA Associate Editor John M. Inadomi, MD, to discuss co-testing with FIT and H pylori stool antigen to help prevent gastric cancer.

Related Content:

  • Fecal Immunochemical Test and Helicobacter pylori Stool Antigen Co-Testing
  • Screening for Helicobacter pylori to Prevent Gastric Cancer

Fecal Immunochemical Test (FIT) and Helicobacter pylori Stool Antigen Co-Testing for Gastric Cancerに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。